* Overall survival data added to Velcade label * Study showed 35 pct reduction in risk of death NEW YORK, Jan 4 (Reuters) - The drug Velcade used to treat the second most common form of blood cancer ...
Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or mantle cell lymphoma. The Food and Drug Administration (FDA) has approved ...
April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...
NEW YORK (MarketWatch) -- Millennium Pharmaceuticals Inc. said Wednesday the U.S. Food and Drug Administration granted priority review for Velcade in patients with newly diagnosed multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results